Wedel, 1 April 2026 – The medac group brings its production sites in Dessau and Brno together under the corporate brand medac. As of 1 April 2026, the former companies Oncotec Pharma Produktion GmbH and oncomed manufacturing a.s. operate under the name medac pharma production.
The new company names are:
• medac pharma production GmbH (Dessau)
• medac pharma production a.s. (Brno)
With this step, medac aligns its production activities under the corporate brand and establishes a clear structure within the group.
Unified brand approach strengthens the corporate presence
Following the rebranding, both production sites operate under the medac brand and apply a shared brand identity. The legal independence of the companies remains unchanged.
The harmonised brand structure provides greater transparency for partners, customers and employees worldwide and supports the long-term development of the medac group as a global pharmaceutical company.
Production in Europe for quality and reliable supply
Manufacturing in Europe has always been a core element of medac’s corporate approach. In-house production capabilities enable the company to maintain high quality standards and ensure a reliable supply of medicines for patients.
The unified naming of the production sites underlines this commitment and strengthens manufacturing capabilities within the medac group.
““The integration of the
Gerhard Wurzer, Chief Operating Officer of the medac group
production sites under the medac brand is a clear
commitment to quality,
reliability and a consistent brand presence”